Lifevantage Corp (LFVN) stock
LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 16/3023% below fair value
$4.97−0.07 (-1.39%)
Close on Nov 13, 2026Market cap $62.26MP/E 23.7Yield 3.72%
Lifevantage enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Lifevantage's enterprise value was $44.16M on Nov 11, 2026, against $74.10M a year earlier. Over the last 5 years it ranged from $24.56M to $249.57M, with a median of $63.72M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $44.16M | -32.1% |
| 2025 | Dec 31, 2025 | $65.09M | -68.1% |
| 2024 | Dec 31, 2024 | $204.25M | +253.1% |
| 2023 | Dec 29, 2023 | $57.84M | +98.7% |
| 2022 | Dec 30, 2022 | $29.10M | -54.3% |
| 2021 | Dec 31, 2021 | $63.72M | -44.5% |
| 2020 | Dec 31, 2020 | $114.74M | -44.6% |
| 2019 | Dec 31, 2019 | $207.03M | +19.1% |
| 2018 | Dec 31, 2018 | $173.82M | +178.6% |
| 2017 | Dec 29, 2017 | $62.39M | -44.9% |
| 2016 | Dec 30, 2016 | $113.27M | -16.8% |
| 2015 | Dec 31, 2015 | $136.16M | -1.0% |
| 2014 | Dec 31, 2014 | $137.57M | -17.3% |
| 2013 | Dec 31, 2013 | $166.27M | -25.1% |
| 2012 | Dec 31, 2012 | $221.96M | +67.9% |
| 2011 | Dec 30, 2011 | $132.18M | – |
See a number that looks wrong?